MENU
+Compare
GERN
Stock ticker: NASDAQ
AS OF
Jan 30 closing price
Price
$2.88
Change
-$0.01 (-0.35%)
Capitalization
1.75B

GERN Geron Corp Forecast, Technical & Fundamental Analysis

a developer of therapeutic products for cancer

Industry Biotechnology
GERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for GERN with price predictions
Jan 29, 2025

GERN's RSI Oscillator ascending out of oversold territory

The RSI Indicator for GERN moved out of oversold territory on January 22, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 23 similar instances when the indicator left oversold territory. In of the 23 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 66 cases where GERN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GERN just turned positive on January 24, 2025. Looking at past instances where GERN's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GERN advanced for three days, in of 224 cases, the price rose further within the following month. The odds of a continued upward trend are .

GERN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 29, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on GERN as a result. In of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GERN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for GERN entered a downward trend on January 23, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GERN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.956) is normal, around the industry mean (15.749). P/E Ratio (0.000) is within average values for comparable stocks, (88.784). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.848). GERN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (61.350) is also within normal values, averaging (276.027).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
GERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

GERN is expected to report earnings to fall 21.50% to -3 cents per share on March 06

Geron Corp GERN Stock Earnings Reports
Q4'24
Est.
$-0.03
Q3'24
Beat
by $0.04
Q2'24
Est.
$-0.10
Q1'24
Beat
by $0.03
Q4'23
Beat
by $0.02
The last earnings report on November 07 showed earnings per share of -3 cents, beating the estimate of -7 cents. With 10.06M shares outstanding, the current market capitalization sits at 1.75B.
A.I. Advisor
published General Information

General Information

a developer of therapeutic products for cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
919 East Hillsdale Boulevard
Phone
+1 650 473-7700
Employees
141
Web
https://www.geron.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACAEX12.990.13
+1.01%
American Century International Gr G
JRANX86.910.34
+0.39%
Janus Henderson Research N
FMDCX15.97N/A
N/A
Federated Hermes Mid-Cap Index Svc
STMDX35.02N/A
N/A
Sterling Capital Real Estate I
NBHEX13.87N/A
N/A
Neuberger Berman Equity Income E

GERN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GERN has been closely correlated with SER. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if GERN jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GERN
1D Price
Change %
GERN100%
-0.35%
SER - GERN
67%
Closely correlated
-0.65%
LIANY - GERN
53%
Loosely correlated
N/A
VCYT - GERN
44%
Loosely correlated
+3.83%
MIRM - GERN
39%
Loosely correlated
-0.33%
NRIX - GERN
37%
Loosely correlated
+1.86%
More

Groups containing GERN

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GERN
1D Price
Change %
GERN100%
-0.35%
GERN
(2 stocks)
76%
Closely correlated
-0.50%